Cargando…
Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212311/ http://dx.doi.org/10.1016/S0016-5085(22)62384-9 |
| _version_ | 1784730554674970624 |
|---|---|
| author | Watanabe, Kenji Hisamatsu, Tadakazu Nakase, Hiroshi Nagase, Kazuko Matsuura, Minoru Aoyama, Nobuo Kobayashi, Taku Sakuraba, Hirotake Yokoyama, Kaoru Nishishita, Masakazu Esaki, Motohiro Hirai, Fumihito Nagahori, Masakazu Nanjo, Sohachi Omori, Teppei Tanida, Satoshi Yokoyama, Yoshihiro Moriya, Kei Maemoto, Atsuo Handa, Osamu Ohmiya, Naoki Shinzaki, Shinichiro Kato, Shingo Tanaka, Hiroki Uraoka, Toshio Takatsu, Noritaka Suzuki, Hideo Takahashi, Kenichiro Umeno, Junji Mishima, Yoshiyuki Tsuchida, Kenji Fujiya, Mikihiro Hiraoka, Sakiko Yamamoto, Shuji Saruta, Masayuki Nojima, Masanori Andoh, Akira |
| author_facet | Watanabe, Kenji Hisamatsu, Tadakazu Nakase, Hiroshi Nagase, Kazuko Matsuura, Minoru Aoyama, Nobuo Kobayashi, Taku Sakuraba, Hirotake Yokoyama, Kaoru Nishishita, Masakazu Esaki, Motohiro Hirai, Fumihito Nagahori, Masakazu Nanjo, Sohachi Omori, Teppei Tanida, Satoshi Yokoyama, Yoshihiro Moriya, Kei Maemoto, Atsuo Handa, Osamu Ohmiya, Naoki Shinzaki, Shinichiro Kato, Shingo Tanaka, Hiroki Uraoka, Toshio Takatsu, Noritaka Suzuki, Hideo Takahashi, Kenichiro Umeno, Junji Mishima, Yoshiyuki Tsuchida, Kenji Fujiya, Mikihiro Hiraoka, Sakiko Yamamoto, Shuji Saruta, Masayuki Nojima, Masanori Andoh, Akira |
| author_sort | Watanabe, Kenji |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212311 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92123112022-06-22 Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES Watanabe, Kenji Hisamatsu, Tadakazu Nakase, Hiroshi Nagase, Kazuko Matsuura, Minoru Aoyama, Nobuo Kobayashi, Taku Sakuraba, Hirotake Yokoyama, Kaoru Nishishita, Masakazu Esaki, Motohiro Hirai, Fumihito Nagahori, Masakazu Nanjo, Sohachi Omori, Teppei Tanida, Satoshi Yokoyama, Yoshihiro Moriya, Kei Maemoto, Atsuo Handa, Osamu Ohmiya, Naoki Shinzaki, Shinichiro Kato, Shingo Tanaka, Hiroki Uraoka, Toshio Takatsu, Noritaka Suzuki, Hideo Takahashi, Kenichiro Umeno, Junji Mishima, Yoshiyuki Tsuchida, Kenji Fujiya, Mikihiro Hiraoka, Sakiko Yamamoto, Shuji Saruta, Masayuki Nojima, Masanori Andoh, Akira Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212311/ http://dx.doi.org/10.1016/S0016-5085(22)62384-9 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AGA Abstracts Watanabe, Kenji Hisamatsu, Tadakazu Nakase, Hiroshi Nagase, Kazuko Matsuura, Minoru Aoyama, Nobuo Kobayashi, Taku Sakuraba, Hirotake Yokoyama, Kaoru Nishishita, Masakazu Esaki, Motohiro Hirai, Fumihito Nagahori, Masakazu Nanjo, Sohachi Omori, Teppei Tanida, Satoshi Yokoyama, Yoshihiro Moriya, Kei Maemoto, Atsuo Handa, Osamu Ohmiya, Naoki Shinzaki, Shinichiro Kato, Shingo Tanaka, Hiroki Uraoka, Toshio Takatsu, Noritaka Suzuki, Hideo Takahashi, Kenichiro Umeno, Junji Mishima, Yoshiyuki Tsuchida, Kenji Fujiya, Mikihiro Hiraoka, Sakiko Yamamoto, Shuji Saruta, Masayuki Nojima, Masanori Andoh, Akira Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES |
| title | Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES |
| title_full | Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES |
| title_fullStr | Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES |
| title_full_unstemmed | Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES |
| title_short | Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES |
| title_sort | tu1546: japan prospective multicenter study for optimization of covid-19 vaccinations based on the immune response and safety profile in inflammatory bowel disease patients: interim analyses |
| topic | AGA Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212311/ http://dx.doi.org/10.1016/S0016-5085(22)62384-9 |
| work_keys_str_mv | AT watanabekenji tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT hisamatsutadakazu tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT nakasehiroshi tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT nagasekazuko tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT matsuuraminoru tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT aoyamanobuo tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT kobayashitaku tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT sakurabahirotake tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT yokoyamakaoru tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT nishishitamasakazu tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT esakimotohiro tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT hiraifumihito tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT nagahorimasakazu tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT nanjosohachi tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT omoriteppei tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT tanidasatoshi tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT yokoyamayoshihiro tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT moriyakei tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT maemotoatsuo tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT handaosamu tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT ohmiyanaoki tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT shinzakishinichiro tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT katoshingo tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT tanakahiroki tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT uraokatoshio tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT takatsunoritaka tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT suzukihideo tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT takahashikenichiro tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT umenojunji tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT mishimayoshiyuki tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT tsuchidakenji tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT fujiyamikihiro tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT hiraokasakiko tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT yamamotoshuji tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT sarutamasayuki tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT nojimamasanori tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses AT andohakira tu1546japanprospectivemulticenterstudyforoptimizationofcovid19vaccinationsbasedontheimmuneresponseandsafetyprofileininflammatoryboweldiseasepatientsinterimanalyses |